versión imprimible
 
 

Neuropathic Pain Therapeutics Summit

Evvnt Promotion / evvnt
-
24.08.2021 - 25.08.2021  Online
Time: 08:00 to 17:00
 
Temas de la conferencia
The First Industry-Dedicated Conference Focused on Accelerating Novel Neuropathic Pain Therapeutics into the Clinic.

The opioid crisis rages on unabated. Meanwhile, the global population continues to age, creating an enormous need for next-generation neuropathic pain treatment and management approaches. This has stimulated a renewed sense of urgency to discover, translate and accelerate non-addictive and clinically effective pain relief therapeutics into the clinic and to patients in pain.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/768538-0?pid=4832

Speakers: Steven Fox, Chairman and Founder, Akelos, Inc, Irving Sucholeiki, President and Chief Executive Officer, Aquilus Pharmaceuticals, Gary J. Bennett, Co-Founder, BioIntervene Inc., and more.
 

Información e inscripción:

https://go.evvnt.com/768538-2?pid=4832
Mr. Customer Service
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
Conference - Industry - Early Bird Available: USD 1199.00, Conference - Academic - Early Bird Available: USD 899.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Österreichische Akademie der ÄrzteEuropean Health Forum GasteinAMREF - African Medical and Research FoundationÄrzte der WeltÖsterreichisches Rotes KreuzÖsterreichische Gesellschaft für Public HealthOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Center of Excellence